The [(18)F]FDG has 109.7 min half-life, there is a period about 6 h between the beginning of [(18)O]H2O irradiation until the PET-CT exam. Any fail in production chain will result in delay to the PET-CT exam. The absence of the position signs from [(18)O]H2O target valve may result in (18)F production loss. Three types of position sensors were tested. After finding the fitter sensor it was possible to reduce the incidence of fails, increasing the reliability in [(18)F]FDG production chain.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.apradiso.2013.09.016 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case Report: Utility of brain [F]FDG PET/CT in the diagnosis of Sydenham's chorea.
Front Nucl Med
December 2024
Radiopharmacist, CRCI2NA-Inserm UMR1307/CNRS UMR 6075, University of Angers, Angers, France.
Sydenham's chorea is an autoimmune reaction against cerebral basal ganglia associated with rheumatic fever, caused by group A beta-hemolytic streptococcus infection. Diagnosis of this condition is difficult because of significant delay between infection onset and symptoms presentation, resulting in few positive biological tests or imaging exams. We report the case of a nine-year-old boy exhibiting hemicorporal abnormal movements with tics for whom [F]FDG PET/CT exam allowed to make the diagnosis, associated with anti-DNase B elevation.
View Article and Find Full Text PDFFeasibility and impact of sentinel lymph node biopsy in patients affected by ano-rectal melanoma.
Tech Coloproctol
January 2025
Department of Surgical Sciences, University of Turin, Turin, Italy.
Introduction: Anorectal melanoma (ARM) is rare and highly lethal neoplasm. It has a poorer prognosis compared with cutaneous ones. Sentinel lymph node biopsy (SLNB) has become the preferred method of nodal staging method for cutaneous melanoma.
View Article and Find Full Text PDFComparative Diagnostic Value of 18F-FDG-PET-CT and Intraoperative Examination in Cervical Cancer Staging.
Medicina (Kaunas)
October 2024
Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia.
: The primary objective of this study is to assess the effectiveness of 18F-FDG-PET-CT in preoperative staging of cervical cancer, focusing on determining surgical operability and exploring the correlation between its quantitative parameters and clinicopathological characteristics. : This retrospective study included 62 cervical cancer patients treated at the Department of Gynecology, Clinic for Operative Oncology at the Institute of Oncology Vojvodina between January 2016 and January 2020, where preoperative clinical examinations and 18F-FDG-PET-CT were performed to assess the extent of cancer, followed by intraoperative and pathohistological examinations of surgically removed specimens to provide a comprehensive evaluation. : The mean tumor size measured by 18F-FDG-PET-CT was slightly greater than that obtained through clinical examination (26.
View Article and Find Full Text PDFComparison of whole-body 18F-FDG-PET/CT with 18F-FDG-PET/CT limited to skull base to upper abdomen for primary staging of lung cancer - a retrospective explorative analysis.
Nuklearmedizin
November 2024
Institut für Nuklearmedizin mit PET-Zentrum, Wiener Gesundheitsverbund Klinik Ottakring, Wien, Austria.
The gold standard for ruling out distant metastases as part of primary staging in lung cancer is whole-body F-FDG-PET/CT, but this method is resource-intensive. Recent evidence suggests that examining only the thorax and upper abdomen may be sufficient 1 2 3. If a limited F-FDG-PET/CT approach proves effective for proper staging, it could lead to quicker examinations and reduced radiation exposure.
View Article and Find Full Text PDFCase report: Neoadjuvant-intent pembrolizumab resulted in complete response in a xeroderma pigmentosum patient with locally advanced resectable cutaneous squamous cell carcinoma of the nose.
Front Med (Lausanne)
October 2024
Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Article Synopsis
- Anti-PD1 antibodies, specifically Pembrolizumab, have emerged as a notable treatment option for skin cancers like melanoma and metastatic squamous cell carcinoma, but their use in resectable cases remains unproven.
- A 49-year-old woman with Xeroderma Pigmentosum and stage IVA cutaneous squamous cell carcinoma opted for neoadjuvant Pembrolizumab treatment instead of surgery, experiencing significant tumor reduction after two cycles.
- Following her positive response, a multidisciplinary team decided on radiation therapy instead of surgical neck dissection, ultimately continuing with adjuvant immunotherapy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!